[Comparison of a salicylate-heparin gel with a monosubstance preparation. Results of a double-blind cross-over study].
D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005439:Flufenamic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005782:Gels; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D008297:Male; D008610:Menthol / Q000627:therapeutic use*; D008875:Middle Aged; D012216:Rheumatic Diseases / Q000188:drug therapy; D013122:Spinal Diseases / Q000188:drug therapy
D000636:Aminosalicylic Acids; D004338:Drug Combinations; D005782:Gels; D008610:Menthol; D005439:Flufenamic Acid; C005521:Dolo-Menthoneurin; D006493:Heparin; C015207:etofenamate
Vergleich eines Salizylat/Heparin-Gels mit einem Monosubstanzpräparat. Ergebnisse einer Doppelblind-cross-over-Studie.